Concerns about subgroup analyses and reason for stopping remdesivir trial. | CMAJ;194(10): E389, 2022 03 14. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Concerns about subgroup analyses and reason for stopping remdesivir trial.

Vijayaraghavan, Bharath Kumar Tirupakuzhi.

Vijayaraghavan BKT; Critical care physician, Apollo Hospitals, Chennai, India.

CMAJ ; 194(10): E389, 2022 03 14.

Article in English | MEDLINE | ID: covidwho-2079786

Subject(s)

Alanine; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/therapeutic use; Alanine/analogs & derivatives; Alanine/therapeutic use; Humans

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alanine Type of study: Randomized controlled trials Limits: Humans Language: English Journal: CMAJ Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Cmaj.81197

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alanine Type of study: Randomized controlled trials Limits: Humans Language: English Journal: CMAJ Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Cmaj.81197